Search Results - "Tang, Shuangyan"

Computational Redesign of a PETase for Plastic Biodegradation under Ambient Condition by the GRAPE Strategy by Cui, Yinglu, Chen, Yanchun, Liu, Xinyue, Dong, Saijun, Tian, Yu’e, Qiao, Yuxin, Mitra, Ruchira, Han, Jing, Li, Chunli, Han, Xu, Liu, Weidong, Chen, Quan, Wei, Wangqing, Wang, Xin, Du, Wenbin, Tang, Shuangyan, Xiang, Hua, Liu, Haiyan, Liang, Yong, Houk, Kendall N, Wu, Bian

“…Nature has provided a fantastic array of enzymes that are responsible for essential biochemical functions but not usually suitable for technological…”
Get full text

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study by Chen, Song, Shuangyan, Tang, Shi, Feng, Cai, Hongjie, Wu, Zhiqiang, Wang, Liguang, Ma, Ping, Zhou, Yuanmin, Mai, Qicong, Wang, Fan, Lai, Jiaming, Chen, Xiaoming, Chen, Huanwei, Guo, Wenbo

“…Intermediate-stage (BCLC-B) hepatocellular carcinoma (HCC) beyond the up-to-11 criteria represent a significant therapeutic challenge due to high and…”
Get full text

Anlotinib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma associated with hepatitis B virus: a retrospective controlled study by Chen, Song, Cai, Hongjie, Wu, Zhiqiang, Tang, Shuangyan, Chen, Ludan, Wang, Fan, Zhuang, Wenquan, Guo, Wenbo

“…To investigate the efficacy and safety of combined treatment of anlotinib and transarterial chemoembolization (TACE) in patients with unresectable…”
Get full text

Atezolizumab plus bevacizumab combined with transarterial embolization plus hepatic arterial infusion-chemotherapy for unresectable hepatocellular carcinoma with a diameter larger than 8 cm: A retrospective study by Guo, Wenbo, Cai, Hongjie, Chen, Song, Wu, Zhiqiang, Wang, Fan, Chen, Ludan, Tang, Shuangyan, Zhuang, Wenquan

“…e14617 Background: The combination of atezolizumab and bevacizumab (Atezo-Bev) has become the standard first-line therapeutic regimen for patients with…”
Get full text

Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma by Cai, Hongjie, Chen, Song, Wu, Zhiqiang, Wang, Fan, Tang, Shuangyan, Li, Dongbing, Wang, Dongliang, Guo, Wenbo

“…Currently, the roles of ZNF692 have been documented exclusively in lung, colon, and cervical cancers. However, its involvement in pan cancer remains unknown…”
Get full text

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study by Cai, Hongjie, Chen, Song, Wu, Zhiqiang, Wang, Fan, Tang, Shuangyan, Chen, Ludan, Guo, Wenbo

“…Local in combination with systemic therapy might be an option for patients with advanced unresectable hepatocellular carcinoma (uHCC). This study examined the…”
Get full text

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study by Chen, Song, Shi, Feng, Wu, Zhiqiang, Wang, Liguang, Cai, Hongjie, Ma, Ping, Zhou, Yuanmin, Mai, Qicong, Wang, Fan, Tang, Shuangyan, Zhuang, Wenquan, Lai, Jiaming, Chen, Xiaoming, Chen, Huanwei, Guo, Wenbo

“…The current therapeutic strategies for high-risk, unresectable hepatocellular carcinoma (HCC) patients demonstrate suboptimal outcomes. This study aimed to…”
Get full text

Design and application of high-throughput screening tools: a review by Tang, Shuangyan, Liang, Chaoning, Jiang, Peixia

“…As an efficient and promising protein engineering strategy, directed evolution includes the construction of mutant libraries and screening of desirable…”
Get more information